Abbvie Shares See 46.36% Volume Spike Ranks 112th in U.S. Trading Activity

Abbvie (ABBV) closed on Sept. 10, 2025, with a 0.58% gain, while trading volume surged 46.36% to $0.95 billion, ranking 112th among U.S. stocks by volume. The biopharmaceutical giant’s shares saw heightened activity amid market speculation surrounding potential regulatory updates and earnings expectations.

Analysts noted that Abbvie’s volume spike likely reflected investor positioning ahead of its upcoming earnings report and ongoing litigation developments. Recent filings indicated mixed progress in patent disputes, which could influence near-term market sentiment. However, no major product approvals or partnership announcements were reported in the immediate period, limiting broader catalysts for the move.

To run this back-test properly, we need to pull a very large data set—daily volume and closing-price information for every U.S.-listed common stock from 2022-01-03 through today (almost four years of data). That will run to many millions of rows and can take a noticeable amount of time. Two approaches are available: a full universe of all NYSE/NASDAQ/AMEX common stocks for maximum accuracy or a representative subset like the Russell 3000 for faster processing. Please specify your preferred universe to proceed.